gimli
AGARWALEYE stock analysis context
DR AGARWALS HEALTH CARE L Stock Context for AI Screening
DR AGARWALS HEALTH CARE L is a mid-cap stock in Healthcare. This page summarizes key screening signals for DR AGARWALS HEALTH CARE L, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about AGARWALEYEPrice
₹479.35
1M return
+3.95%
3M return
+7.50%
Market cap
₹15,194.58 cr
PE
157.69
ROE
+5.83%
RSI
65.10
Turnover
₹11.86 cr
Why it can matter in screens
- Momentum: AGARWALEYE is above 50DMA, above 200DMA; RSI is 65.10.
- Returns: 1M +3.95%, 3M +7.50%, 6M -2.92%.
- Liquidity: latest turnover is ₹11.86 cr.
- Valuation: PE 157.69, PB n/a, ROE +5.83%, ROCE +9.43%.
- Growth: 3Y sales CAGR +34.83%, 3Y profit CAGR +30.33%.
Try these prompts
- Analyze DR AGARWALS HEALTH CARE L with valuation, momentum and industry peers
- Compare AGARWALEYE with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare AGARWALEYE with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.